214
Views
15
CrossRef citations to date
0
Altmetric
Original Article

Evaluation of the effects of olopatadine ophthalmic solution, 0.2% on the ocular surface of patients with allergic conjunctivitis and dry eye*

, , &
Pages 441-447 | Accepted 30 Nov 2007, Published online: 31 Dec 2007

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

William B Trattler, Parag A Majmudar, Eric D Donnenfeld, Marguerite B McDonald, Karl G Stonecipher & Damien F Goldberg. (2017) The Prospective Health Assessment of Cataract Patients’ Ocular Surface (PHACO) study: the effect of dry eye. Clinical Ophthalmology 11, pages 1423-1430.
Read now
Rengin Aslıhan Kurt, Ömür Ucakhan-Gündüz & Kaan Gündüz. (2010) Olopatadine 0.1% and 0.2% ophthalmic solution for the management of ocular allergy. Expert Review of Ophthalmology 5:3, pages 287-296.
Read now

Articles from other publishers (13)

José Alvaro P. Gomes, Dimitri T. Azar, Christophe Baudouin, Etty Bitton, Wei Chen, Farhad Hafezi, Pedram Hamrah, Ruth E. Hogg, Jutta Horwath-Winter, Georgios A. Kontadakis, Jodhbir S. Mehta, Elisabeth M. Messmer, Victor L. Perez, David Zadok & Mark D.P. Willcox. (2023) TFOS Lifestyle: Impact of elective medications and procedures on the ocular surface. The Ocular Surface 29, pages 331-385.
Crossref
Julia Prinz, Nicola Maffulli, Matthias Fuest, Peter Walter, Frank Hildebrand & Filippo Migliorini. (2022) Placebo administration for dry eye disease: a level I evidence based systematic review and meta-analysis. International Journal of Clinical Pharmacy 44:5, pages 1087-1101.
Crossref
Cemal ÇavdarliPınar Topcu Yilmaz. (2020) Pupil Diameter, Corneal Thickness, and Anterior Chamber Alterations Following Topical Olopatadine Hydrochloride 0.1%: A Single-Masked Randomized Controlled Clinical Study. Journal of Ocular Pharmacology and Therapeutics 36:7, pages 540-544.
Crossref
Panchali Kanvatirth, Rose E. Jeeves, Joanna Bacon, Gurdyal S. Besra & Luke J. Alderwick. (2019) Utilisation of the Prestwick Chemical Library to identify drugs that inhibit the growth of mycobacteria. PLOS ONE 14:3, pages e0213713.
Crossref
Alper Yenigun, Zeynep Dadaci, Gulay Ozel Sahin & Ahmet Elbay. (2016) Prevalence of Allergic Rhinitis Symptoms and Positive Skin-prick Test Results in Patients with Dry Eye. American Journal of Rhinology & Allergy 30:2, pages e26-e29.
Crossref
Punchama Pacharn & Pakit Vichyanond. (2013) Immunomodulators for conjunctivitis. Current Opinion in Allergy & Clinical Immunology 13:5, pages 550-557.
Crossref
Milton M. Hom & Leonard Bielory. (2013) The Anatomical and Functional Relationship between Allergic Conjunctivitis and Allergic Rhinitis. Allergy & Rhinology 4:3, pages ar.2013.4.0067.
Crossref
John Wong, Wanwen Lan, Li Ming Ong & Louis Tong. (2011) Non-hormonal Systemic Medications and Dry Eye. The Ocular Surface 9:4, pages 212-226.
Crossref
Mark B. Abelson, James T. McLaughlin & Paul J. Gomes. (2011) Antihistamines in Ocular Allergy: Are They All Created Equal?. Current Allergy and Asthma Reports 11:3, pages 205-211.
Crossref
Saurbhi Khurana, Namrata Sharma, Tushar Agarwal, Bhavna Chawla, T. Velpandian, Radhika Tandon & Jeewan S. Titiyal. (2010) Comparison of Olopatadine and Fluorometholone in Contact Lens-Induced Papillary Conjunctivitis. Eye & Contact Lens: Science & Clinical Practice 36:4, pages 210-214.
Crossref
Jerzy Kruszewski. (2009) Leki przeciwhistaminowe w leczeniu alergicznego nieżytu nosa – uaktualnienie 2008/2009. Otolaryngologia Polska 63:7, pages 5-10.
Crossref
. (2009) Current World Literature. Current Opinion in Ophthalmology 20:4, pages 333-341.
Crossref
. (2008) Current World Literature. Current Opinion in Ophthalmology 19:5, pages 435-443.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.